NCT04104321 - A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

December 8, 2022

Study Completion Date

June 30, 2027

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

DRUG

Aramchol free acid

Aramchol 300 mg BID

DRUG

Placebo

Placebo BID

Trial Locations (2)

The Public Health Trust of Miami-Dade County, Florida, dba the Jackson Health System, Miami

Texas Clinical Research Institute, LLC, Arlington